FMR CORP 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-13 09:02 am Sale |
2023-11-10 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
FMR CORP | 3,551,261 3.771% |
-5,587,912 (-61.14%) |
Filing |
| 2023-02-09 08:23 am Purchase |
2023-02-09 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
FMR CORP | 9,139,173 14.999% |
1,594,961 (+21.14%) |
Filing |
| 2022-02-09 09:09 am Purchase |
2022-02-08 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
FMR CORP | 7,544,212 14.999% |
999,048 (+15.26%) |
Filing |
| 2021-02-08 10:15 am Purchase |
2021-02-05 | 13G | Arcutis Biotherapeutics, Inc. ARQT |
FMR CORP | 6,545,164 14.999% |
2,486,155 (+61.25%) |
Filing |